Novasys gets $13 million financing:
This article was originally published in Clinica
Executive Summary
Novasys has secured $13 million in a financing, which will enable it to continue developing an investigational, non-surgical treatment for female stress urinary incontinence. The Sunnyvale, California company recently completed the treatment of 41 women with the condition - it is currently collecting and analysing the clinical results. Novasys says that 80% of the 25 million sufferers of bladder control problems in the US are women. Stress urinary incontinence is the most common incontinence problem for women.